Intuitive Surgical, Inc. (NASDAQ:ISRG) Position Trimmed by Catalina Capital Group LLC

Catalina Capital Group LLC lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 28.0% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,955 shares of the medical equipment provider's stock after selling 759 shares during the period. Catalina Capital Group LLC's holdings in Intuitive Surgical were worth $968,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. increased its stake in shares of Intuitive Surgical by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock worth $16,813,478,000 after buying an additional 360,591 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of Intuitive Surgical by 3.2% in the fourth quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider's stock worth $4,039,200,000 after buying an additional 243,802 shares during the last quarter. Fisher Asset Management LLC increased its stake in shares of Intuitive Surgical by 1.8% in the fourth quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider's stock worth $2,541,356,000 after buying an additional 86,488 shares during the last quarter. Norges Bank acquired a new position in Intuitive Surgical in the fourth quarter worth $2,401,493,000. Finally, Invesco Ltd. boosted its holdings in Intuitive Surgical by 7.7% in the fourth quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider's stock worth $2,165,184,000 after purchasing an additional 295,025 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Down 0.0%

Intuitive Surgical stock traded down $0.13 during midday trading on Friday, hitting $509.36. The company's stock had a trading volume of 2,827,555 shares, compared to its average volume of 1,682,019. The stock's 50-day moving average price is $527.71 and its 200-day moving average price is $537.69. Intuitive Surgical, Inc. has a 12 month low of $413.82 and a 12 month high of $616.00. The company has a market capitalization of $182.56 billion, a PE ratio of 74.69, a price-to-earnings-growth ratio of 5.40 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The firm had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. During the same period in the previous year, the business earned $1.50 earnings per share. As a group, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. Royal Bank Of Canada decreased their price objective on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Citigroup reaffirmed a "buy" rating and issued a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Erste Group Bank raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Thursday, June 5th. Evercore ISI reduced their price target on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a report on Wednesday, April 23rd. Finally, Robert W. Baird reduced their price target on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $588.95.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Gary Loeb sold 1,700 shares of the business's stock in a transaction dated Friday, April 25th. The stock was sold at an average price of $513.18, for a total transaction of $872,406.00. Following the sale, the executive vice president now owns 2,245 shares in the company, valued at approximately $1,152,089.10. The trade was a 43.09% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Robert Desantis sold 188 shares of the business's stock in a transaction dated Monday, April 28th. The stock was sold at an average price of $515.91, for a total value of $96,991.08. Following the sale, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,695,113.84. The trade was a 3.47% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 4,998 shares of company stock worth $2,611,577. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.